A new study found postmenopausal women who took nonsteroidal anti-inflammatory drugs for at least 10 years had a lower risk of dying from colorectal cancer than women who did not use NSAIDs at all, said an American Association for Cancer Research news release.
Researchers evaluated the association between aspirin and nonaspirin NSAID use and colorectal cancer mortality in 160,143 postmenopausal women enrolled in the Women’s Health Initiative. They found 2,119 cases of colorectal cancer and 492 deaths due to colorectal cancer.
Although the researchers found no clear link between NSAID use and colorectal cancer mortality, the risk of death from colorectal cancer was 30 percent less for women who had been taking NSAIDs for at least 10 years prior to the study and who continued use of NSAIDs for three years after the study enrollment.
Related Articles about Colorectal Cancer:
Researchers Link Bacterium and Colon Cancer
Study: Metformin Therapy May Reduce Risk of Colon Cancer in Diabetics
Bloodstream Infections Linked to Colorectal Cancer
Researchers evaluated the association between aspirin and nonaspirin NSAID use and colorectal cancer mortality in 160,143 postmenopausal women enrolled in the Women’s Health Initiative. They found 2,119 cases of colorectal cancer and 492 deaths due to colorectal cancer.
Although the researchers found no clear link between NSAID use and colorectal cancer mortality, the risk of death from colorectal cancer was 30 percent less for women who had been taking NSAIDs for at least 10 years prior to the study and who continued use of NSAIDs for three years after the study enrollment.
Related Articles about Colorectal Cancer:
Researchers Link Bacterium and Colon Cancer
Study: Metformin Therapy May Reduce Risk of Colon Cancer in Diabetics
Bloodstream Infections Linked to Colorectal Cancer